Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication 
Tizoxanide
Potential treatment - theoretical effect Experimental Antiviral Jan/25/2021
Z-FA-FMK
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/24/2021
Human amnionic fluid
Potential treatment - clinical evidence Experimental Other treatment Jan/22/2021
RBD-SpyVLP
Potential treatment - pre-clinical evidence Experimental Vaccine Jan/22/2021
Pontacyl violet 6R
Potential treatment - theoretical effect Experimental Antiviral Jan/21/2021
1-[1-(6-Chloroquinolin-4-yl)piperidin-4-yl]piperidin-3-ol
Potential treatment - theoretical effect Experimental Antiviral Jan/20/2021
(1R,2R)-2-N-(7-Chloroquinolin-4-yl)cyclohexane-1,2-diamine
Potential treatment - theoretical effect Experimental Antiviral Jan/20/2021
Cov2-16
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/20/2021
CoV2-09
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/20/2021
CoV2-26
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/20/2021
CoV2-06
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/20/2021
CoV2-12
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/20/2021
CoV2-14
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/20/2021
[3-(5-methoxy-2-hydroxy benzylidene amino)-2(5-methoxy-2-hydroxyphenyl)-2,3-dihydro quinazoline-4(1H)-one]
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/19/2021
Stenoparib
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/19/2021
(Recombinant) IL-2
Potential treatment - clinical evidence Experimental Other treatment Jan/18/2021
1,2,3-triazole-phtalimide compound E40
Potential treatment - theoretical effect Experimental Antiviral Jan/18/2021
Maduramicin
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/15/2021
Bisindolylmaleimide IX
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/14/2021
HP-OVA
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/14/2021